{"DataElement":{"publicId":"2431599","version":"1","preferredName":"Gleason Histopathologic Grade Total Gleason Score Integer","preferredDefinition":"Value of predominant pattern plus second most common pattern (or if 3 patterns present, predominant pattern plus worst pattern of remaining 2) in invasive prostate carcinoma.","longName":"2431391v1.0:2434127v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2431391","version":"1","preferredName":"Gleason Grade for Prostate Cancer Total Gleason Score For Prostate Cancer","preferredDefinition":"definition pending_definition pending","longName":"2431294v1.0:2431251v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2431294","version":"1","preferredName":"Gleason Grade for Prostate Cancer","preferredDefinition":"definition pending","longName":"C28107","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Grading System","conceptCode":"C28107","definition":"A grading system for prostatic carcinoma based on the microscopic glandular architectural patterns of the malignant epithelial cells. Nuclear atypia is not evaluated. It defines five patterns or grades which reflect decreasing differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF477-9AD8-3BD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2431251","version":"1","preferredName":"Total Gleason Score For Prostate Cancer","preferredDefinition":"definition pending","longName":"C48602","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total Gleason Score for Prostate Cancer","conceptCode":"C48602","definition":"The value of the sum of the primary and secondary Gleason scores (range 2-10). If three patterns are identified, it is the sum of the primary pattern score and the score of the least well-differentiated pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCE81E-9A1F-3582-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE0BE8-0CDD-44C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"UMLLDR","dateModified":"2016-10-25","changeDescription":"Permission to Release DEC granted by primary curator in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2434127","version":"1","preferredName":"Gleason Score for Prostate Cancer Total Integer","preferredDefinition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._A number with no fractional part.","longName":"2434127v1","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"2","minValue":"2","maxValue":"10","decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2183782","version":"1","preferredName":"NCIP","preferredDefinition":"Cancer Biomedical Informatics Grid","longName":"NCIP","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DACB2549-3BE3-73F7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2434126","version":"1","preferredName":"Gleason Score Total Integer","preferredDefinition":"A system of grading prostate cancer cells to determine the best treatment and to predict how well a person is likely to do. A low Gleason score means the cancer cells are very similar to normal prostate cells; a high Gleason score means the cancer cells are very different from normal. :Pertaining to an entirety or whole, also constituting the full quantity or extent; complete.:A number with no fractional part.","longName":"C28084:C25304:C45255","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score for Prostate Cancer","conceptCode":"C28084","definition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06674CCB-D059-04A9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06674CCB-D05A-04A9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-28","modifiedBy":"CURTIST","dateModified":"2010-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2534075","version":"1.2","longName":"caTISSUE CAE","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812224","version":"1","longName":"edu.pitt.cabig.cae.domain.prostate","context":"NCIP"}]},{"publicId":"2857187","version":"1","longName":"CAP Cancer Checklists","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812065","version":"1","longName":"edu.upmc.opi.cabig.caties.cap.domain.prostate","context":"NCIP"}]},{"publicId":"3314514","version":"1","longName":"Under Review","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"3351777","version":"1","longName":"6701","context":"ECOG-ACRIN"}]},{"publicId":"5542681","version":"1","longName":"EDRN_CDE_Project","context":"EDRN","ClassificationSchemeItems":[{"publicId":"5543567","version":"1","longName":"Reused-CDEs","context":"EDRN"},{"publicId":"5542682","version":"1","longName":"Biospecimen CDEs","context":"EDRN"}]}],"AlternateNames":[{"name":"edu.pitt.cabig.cae.domain.prostate.GleasonHistologicGrade.totalGleasonScore","type":"UML Qualified Attr","context":"NCIP"},{"name":"GleasonHistologicGrade:totalGleasonScore","type":"UML Class:UML Attr","context":"NCIP"},{"name":"edu.upmc.opi.cabig.caties.cap.domain.prostate.GleasonHistopathologicGrade.totalGleasonScore","type":"UML Qualified Attr","context":"NCIP"},{"name":"GleasonHistopathologicGrade:totalGleasonScore","type":"UML Class:UML Attr","context":"NCIP"},{"name":"ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"EDRN","type":"USED_BY","context":"EDRN"},{"name":"Reused-CDEs.Gleason_Grading_System.SPECIMEN_TISSUE_GLEASONOVERALLSCORE_VALUE_1697","type":"UML Qualified Attr","context":"EDRN"},{"name":"Gleason_Grading_System:SPECIMEN_TISSUE_GLEASONOVERALLSCORE_VALUE_1697","type":"UML Class:UML Attr","context":"EDRN"}],"ReferenceDocuments":[{"name":"Total Gleason Score","type":"Preferred Question Text","description":"Total Gleason Score","url":null,"context":"NCIP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Gleason Score, Combined","url":null,"context":"CTEP"},{"name":"ACRIN Text","type":"Alternate Question Text","description":"Gleason Score","url":null,"context":"ECOG-ACRIN"}],"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE6E0A-B309-61A3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"UMLLDR","dateModified":"2016-10-25","changeDescription":"Permission to Release CDE granted by primary curator, Linda Schmandt, in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}